BearMarketBard

The Nasdaq-100 index delivered solid 20% returns throughout 2025, riding a wave of optimism around generative artificial intelligence. Yet this expanding field remains largely unprofitable, with emerging AI leaders like OpenAI and Anthropic burning through billions quarterly to fund the expensive

Warren Buffett's track record speaks for itself—even as he has passed leadership of Berkshire Hathaway to Greg Abel, the company's investment portfolio remains a masterclass in stock selection. Whether directly chosen by Buffett or acquired under his strategic oversight, the stocks held by Berkshire

Morgan Stanley's aggressive pivot toward wealth and asset management over the past 15 years represents far more than a simple revenue diversification play. It marks a fundamental transformation in how the firm generates profit—one that insulates it from the volatile cycles of investment banking and

Defense contractor Kratos Defense & Security Solutions saw its stock recover Tuesday following four consecutive trading days of losses. The company disclosed that it had secured several military contracts valued at $65 million combined, intended for designing, developing, and delivering training

Chip Wilson, Lululemon's founder, criticized the brand's inclusivity initiatives, claiming it tries to please everyone while contradicting its identity. His controversial comments on diversity in marketing prompted Lululemon to assert their commitment to inclusivity, signaling a significant clash between his views and the company's current direction.

Ansell's TouchNTuff 93-800 gloves offer superior acetone resistance and durability, reducing glove changes and improving safety in solvent-intensive industries. Their innovative design promotes worker safety and operational efficiency.

Novo Nordisk's REIMAGINE 2 trial shows that CagriSema, combining cagrilintide and semaglutide, outperforms semaglutide alone in managing blood glucose and reducing weight in type 2 diabetes patients. Results indicate significant HbA1c and weight reductions, supporting CagriSema's potential as an innovative treatment option.

Asia's markets are bracing for mixed signals as Singapore's benchmark index continues its downward trajectory. The Straits Times Index has now slipped across the board for two consecutive trading sessions, losing nearly 40 points or 0.8 percent during that period. Currently hovering just above the 4

Ingersoll Rand Inc. (IR), a leading manufacturer of flow control and compression equipment, caught investor attention with a 5.4% share price jump in the most recent trading session, closing at $93.72. This movement represented notably higher trading volume than typical, signaling genuine market

Earning $90,000 annually puts you above the U.S. median household income of around $71,000 — yet the housing market might still feel out of reach. The good news? That six-figure-ish salary gives you more purchasing power than many realize. Understanding how much house you can actually afford on a $9

As the U.S. dollar continues its downward trajectory, a compelling investment opportunity is emerging for global investors. Emerging markets ETFs have captured significant attention, riding the wave of currency depreciation and shifting capital flows. Understanding the mechanics behind this trend re

Kyowa Kirin has ended its partnership with Amgen on rocatinlimab, a promising treatment for atopic dermatitis, following strong clinical trial results. The move allows Kyowa Kirin to regain full control of the drug's development while Amgen retains manufacturing responsibilities, reflecting ongoing shifts in the pharmaceutical sector.

South Korean automotive components manufacturer Hyundai Mobis (KOSE:012330) has attracted renewed analyst attention following a substantial revision to its valuation estimates. The one-year average price target has been raised to ₩511,333.85 per share, marking a notable shift in market sentiment

Perspective Therapeutics secured $175 million through share offerings and pre-funded warrants to advance its innovative cancer treatments using alpha-emitting isotope 212 Pb. The funding will support three clinical candidates and expand manufacturing capabilities.

When a company earns interest from loans, investments, or overdue invoices, the accounting treatment depends on a critical distinction: whether the interest has been received or merely earned. Understanding how interest receivable is recorded as a debit asset versus how interest revenue is

Building wealth through stock investing requires more than just luck—it demands a structured approach to picking the right equities for your unique situation. Whether you're a seasoned investor or just starting out, learning how to pick the best stocks involves understanding your financial goals, as

Perseus Mining's consensus price target has just been revised upward to $4.83 per share, marking a significant 13.37% increase from the previous $4.26 estimate issued on December 20, 2025. This latest figure represents a weighted average of analyst projections currently ranging from $4.34 to $5.61 p

Steris delivered solid third-quarter results as of December 2025, posting $1.5 billion in revenue—a 9.2% year-over-year increase that surpassed analyst consensus by 1.08%. Earnings per share reached $2.53, matching consensus expectations despite a narrow -0.1% variance, signaling consistent

Qiagen N.V. (QGEN) delivered Q4 2025 results that exceeded analyst profit expectations, yet its forward guidance for 2026 disappointed investors, prompting an immediate negative market reaction to the biotechnology company's earnings announcement.
Q4 Performance Surpasses Wall Street